Skip to content

Clinical trials

Pathologic Processes trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20142
20151
20161
20171
20181
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asker & Baerum Hospital1
AstraZeneca1
Eli Lilly and Company1
Hutchmed1
KAI Pharmaceuticals1
Norwegian University of Science and Technology1
Oslo University Hospital1
Pfizer1
University Hospital, Akershus1
Zealand Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes10
Cardiovascular Diseases3
Heart Diseases3
Arrhythmias, Cardiac2
Atrial Fibrillation2
Hematologic Diseases2
Immune System Diseases2
Inflammation2
Lung Diseases2
Nervous System Diseases2

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.